Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
Objective:
To determine activity of combo of Irinotecan + Temozolomide To further characterize any
toxicity associated w combo of Irinotecan + Temozolomide